NCT04612907View on ClinicalTrials.gov

Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2032

Conditions
Prostate CancerRadiotherapy Side EffectMetastatic Cancer
Interventions
RADIATION

Moderate hypo-fractionation

Patients will receive four weeks of radiotherapy

RADIATION

Ultra-hypo-fractionation

Patients will receive two and a half weeks of radiotherapy

Trial Locations (1)

90596

RECRUITING

Cancercenter University hospital of Umeå, Umeå

All Listed Sponsors
lead

Umeå University

OTHER